Molecular Guided Therapy Provides Sustained Clinical Response in Refractory Choroid Plexus Carcinoma

por Cornelius, Albert, Foley, Jessica, Bond, Jeffrey, Nagulapally, Abhinav B., Steinbrecher, Julie, Hendricks, William P. D., Rich, Maria, Yendrembam, Sangeeta, Bergendahl, Genevieve, Trent, Jeffrey M., Sholler, Giselle S.
Publicado 2017

A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma

por Lewis, Elizabeth C., Kraveka, Jacqueline M., Ferguson, William, Eslin, Don, Brown, Valerie I., Bergendahl, Genevieve, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Zage, Peter, Rawwas, Jawhar, Rich, Maria, Lorenzi, Elizabeth, Broglio, Kristine, Berry, Donald, Saulnier Sholler, Giselle L.
Publicado 2020

Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma

por Saulnier Sholler, Giselle L, Bond, Jeffrey P, Bergendahl, Genevieve, Dutta, Akshita, Dragon, Julie, Neville, Kathleen, Ferguson, William, Roberts, William, Eslin, Don, Kraveka, Jacqueline, Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal, Merchant, Melinda, Ashikaga, Takamaru, Hanna, Gina, Lescault, Pamela Jean, Siniard, Ashley, Corneveaux, Jason, Huentelman, Matthew, Trent, Jeffrey
Publicado 2015

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

por Sholler, Giselle L. Saulnier, Ferguson, William, Bergendahl, Genevieve, Bond, Jeffrey P., Neville, Kathleen, Eslin, Don, Brown, Valerie, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Parikh, Nehal S., Eshun, Francis, Zage, Peter, Rawwas, Jawhar, Sencer, Susan, Pankiewicz, Debra, Quinn, Monique, Rich, Maria, Junewick, Joseph, Kraveka, Jacqueline M.
Publicado 2018

A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma

por Saulnier Sholler, Giselle L., Gerner, Eugene W., Bergendahl, Genevieve, MacArthur, Robert B., VanderWerff, Alyssa, Ashikaga, Takamaru, Bond, Jeffrey P., Ferguson, William, Roberts, William, Wada, Randal K., Eslin, Don, Kraveka, Jacqueline M., Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal S., Neville, Kathleen, Sender, Leonard, Higgins, Timothy, Kawakita, Masao, Hiramatsu, Kyoko, Moriya, Shun-suke, Bachmann, André S.
Publicado 2015

A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma

por Kraveka, Jacqueline M., Lewis, Elizabeth C., Bergendahl, Genevieve, Ferguson, William, Oesterheld, Javier, Kim, Elizabeth, Nagulapally, Abhinav B., Dykema, Karl J., Brown, Valerie I., Roberts, William D., Mitchell, Deanna, Eslin, Don, Hanson, Derek, Isakoff, Michael S., Wada, Randal K., Harrod, Virginia L., Rawwas, Jawhar, Hanna, Gina, Hendricks, William P. D., Byron, Sara A., Snuderl, Matija, Serrano, Jonathan, Trent, Jeffrey M., Saulnier Sholler, Giselle L.
Publicado 2022